Companies · Pharmaceuticals

IPM Safety Services, Inc.

WAYNE · Pharmaceuticals

Diligence memoA one-page analyst read on IPM Safety Services, Inc. — recommendation, valuation, rhythm, risks.
$1.0M
Total raised · real
1
Rounds
Latest step-up
Top 81%
Sector rank · raised
Pre-Seed
Latest stage · inferred · Mon Mar 25 2013 00:00:00 GMT+0000 (Coordinated Universal Time)

IPM Safety Services, Inc. looks over-valued against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the pharma sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Over-valued
  • Modeled value is 4.17× the median modeled value of Pre-Seed Pharmaceuticals companies in 2013–2015 (87 peers) — value vs value, same stage and era.
Dormant
  • Last raise 13.3 yr ago; this sector typically re-raises about every 13 months.
  • Only one round on record and long silent — often defunct, acquired, or gone quiet.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Pharmaceuticals

IPM Safety Services, Inc. is one of 1613 Pharmaceuticals companies tracked from WAYNE. By capital raised it ranks in the long tail (ahead of 20% of sector peers), and mid-pack by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$13M$25M$38M$50MPre-Seed · 2013-03-25 Raised $1.0M (real) Modeled valuation $47M (est)$1.0M$47MPre-Seed2013

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Pre-Seed$1.0M · 2013

Stages are modeled from round size (public records carry no series label). Ladder is contiguous — every modeled rung has a record.

Modeled valuation trajectory
$47.3M
Base estimate est.
$560K
Conservative case
$536.3M
Upside case
$5.6M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Pre-Seeda round under $1.0M). Valuation is modeled from stage benchmarks scaled by the pharma sector profile. Directional, not a quoted figure.

Not enough modeled valuation points to chart a trajectory.

Model inputs · modeled:benchmark-stage-stepup-v1
18%
Dilution assumption
Implied ownership sold in the financing.
25%
Survival probability
10% low · 46% high
1.80×/yr
Annual markup
2.44×/yr upside case
6.0 yr
Elapsed time used
13.3 yr actual, capped for stale marks
pharma
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
Avg between rounds
Capital velocity
13.3 yr
On record since
2013
First round
1
Rounds on file
How it compares to the market

Benchmarked against 1613 companies in Pharmaceuticals. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 0.1× of median
This company$1.0M
Sector median$8.1M
Latest round — vs other Pre-Seed rounds in sector (real $, this stage) 2.4× above median
This company$1.0M
Sector median$421K
Modeled value — vs sector median (estimate, all stages) 0.6× of median
This company$47.3M
Sector median$76.1M

Raised more than 20% of sector peers (real $). Modeled value above 42% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Pre-Seed) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #1 of 87.

This companyCohort peer
$10.0M$100.0M$100K$1.0M$10.0MCapital raised (log)Scioderm, LLC · Pre-Seed Raised $1.0M · modeled $47.3M (est)Chondrial Therapeutics, LLC · Pre-Seed Raised $1.6M · modeled $47.3M (est)OnCore Biopharma, Inc. · Pre-Seed Raised $1.0M · modeled $47.3M (est)VR1 Corp · Pre-Seed Raised $2.5M · modeled $42.6M (est)Maia Pharmaceuticals, Inc. · Pre-Seed Raised $845K · modeled $40.0M (est)Dolor Technologies LLC · Pre-Seed Raised $800K · modeled $37.8M (est)Sujana Biotech, LLC · Pre-Seed Raised $800K · modeled $37.8M (est)Ucb S.A. · Pre-Seed Raised $788K · modeled $37.3M (est)Salarius Pharmaceuticals, LLC · Pre-Seed Raised $1.0M · modeled $36.7M (est)Antivirus Therapeutics, Inc. · Pre-Seed Raised $743K · modeled $35.1M (est)Lobesity Investors LLC · Pre-Seed Raised $723K · modeled $34.2M (est)IPM Safety Services, Inc. (this company) Raised $1.0M · modeled $47.3M (est)IPM Safety Services, Inc.
CompanyStageRaised · realValue · estvs peer med.
IPM Safety Services, Inc. this companyPre-Seed$1.0M$47.3M4.17×
Scioderm, LLCPre-Seed$1.0M$47.3M4.17×
Chondrial Therapeutics, LLCPre-Seed$1.6M$47.3M4.17×
OnCore Biopharma, Inc.Pre-Seed$1.0M$47.3M4.17×
VR1 CorpPre-Seed$2.5M$42.6M3.75×
Maia Pharmaceuticals, Inc.Pre-Seed$845K$40.0M3.52×
Dolor Technologies LLCPre-Seed$800K$37.8M3.33×
Sujana Biotech, LLCPre-Seed$800K$37.8M3.33×
Ucb S.A.Pre-Seed$788K$37.3M3.28×
Salarius Pharmaceuticals, LLCPre-Seed$1.0M$36.7M3.23×
Antivirus Therapeutics, Inc.Pre-Seed$743K$35.1M3.09×
Lobesity Investors LLCPre-Seed$723K$34.2M3.01×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Pre-Seed$1.0M2013-03-25$5.6M$47.3M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Pre-Seed$1.0M2013-03-25
    • First recorded raise — entered as Pre-Seed.
Intelligence
Modeled next raise
$1.6M
Modeled next size est.range $1.0M$2.6M
Last step-up
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Edward J. Brennan2 other2013-03
James R Douglass2 other2013-03
Angela K Pitwood1 other2013-03
James K. Bannon1 other2013-03
John W. Lynch1 other2013-03
Bruce D. Wietlisbach2013-03
Registry & provenance

IPM Safety Services, Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1575234
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
InClinica, Inc.Other Health CareSeed$5.7M$9.3Mnetwork4 shared operators
Armgo Pharma IncPharmaceuticalsPre-Seed$1.0M$47.3Msame sector · same stage
Blake Insomnia Therapeutics, Inc.PharmaceuticalsPre-Seed$1.0M$47.3Msame sector · same stage
Elion Oncology, Inc.PharmaceuticalsPre-Seed$1.0M$47.3Msame sector · same stage
Enfuego Therapeutics, Inc.PharmaceuticalsPre-Seed$1.0M$27.0Msame sector · same stage
Entopica Therapeutics, Inc.PharmaceuticalsPre-Seed$1.0M$47.3Msame sector · same stage
Essentia Pharma Florida, LlcPharmaceuticalsPre-Seed$1.0M$47.3Msame sector · same stage
Essentia Pharma Socal, LlcPharmaceuticalsPre-Seed$1.0M$47.3Msame sector · same stage
Frequently asked
How much funding has IPM Safety Services, Inc. raised?
IPM Safety Services, Inc. has raised approximately $1.0M in disclosed capital across 1 recorded financing round, aggregated from public filings.
What is IPM Safety Services, Inc.'s estimated valuation?
Provath's modeled valuation for IPM Safety Services, Inc. is approximately $47.3M (modeled range $560K–$536.3M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is IPM Safety Services, Inc. at?
IPM Safety Services, Inc.'s latest modeled financing stage is Pre-Seed. Its most recent recorded round closed around Mon Mar 25.
What does IPM Safety Services, Inc. do and where is it based?
IPM Safety Services, Inc. operates in the Pharmaceuticals sector, based in WAYNE.
Explore related

See where IPM Safety Services, Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at IPM Safety Services, Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.